Strona 4 - Najlepsi lekarze do leczenia raka żołądka, 2 stadium – TOP 101 lekarz

Specjalizuje się w chirurgii laparoskopowej raka żołądka. Szkolił się na Uniwersytecie Stambulskim, jednej z najlepszych uczelni medycznych w Turcji.

• Certyfikowany chirurg ogólny z ponad 20-letnim doświadczeniem
• Ukończył zaawansowane szkolenia w zakresie laparoskopowej chirurgii bariatrycznej oraz onkologicznej
• Posiada ekspercką wiedzę w stosowaniu technik małoinwazyjnych, które sprzyjają szybszej rekonwalescencji pacjentów

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.

He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.

His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Profesor Tamar Jablonski-Perec kieruje oddziałem onkologii w Centrum Medycznym Hadassah. Odbyła staż w Sloan-Kettering Cancer Center w Nowym Jorku.

• Kieruje Instytutem Onkologii od 1994 roku
• Specjalizuje się w leczeniu raka piersi
• Jest profesorem na Wydziale Onkologii Uniwersytetu Hebrajskiego
• Należy do międzynarodowych stowarzyszeń onkologicznych
• Otrzymała stypendium Szkoły Medycznej Hadassah

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Dr Alexander Beny kieruje Oddziałem Nowotworów Układu Pokarmowego w Centrum Medycznym Rambam. Specjalizuje się w leczeniu raka żołądka.

• Certyfikowany onkolog z bogatym doświadczeniem w zakresie onkologii klinicznej i radioterapii
• Dyrektor Oddziału Nowotworów Układu Pokarmowego w Centrum Medycznym Rambam
• Biegle posługuje się językiem angielskim i hebrajskim, co ułatwia kontakt z pacjentami zagranicznymi
• Ukończył specjalistyczne szkolenie w zakresie nowoczesnych technik brachyterapii

Specjalizuje się w chirurgii raka żołądka, posiadając szerokie doświadczenie w zabiegach onkologicznych i bariatrycznych w BAH International.

• Posiada wysokie kwalifikacje w chirurgii trzustki i dróg żółciowych
• Koncentruje się na technikach małoinwazyjnych
• Doświadczony w zaawansowanych operacjach leczenia otyłości i cukrzycy

Prof. Thomas W. Kraus wykonał ponad 3000 skomplikowanych operacji. W klinice Nordwest specjalizuje się w onkologii żołądka oraz chorobach wątroby.

• Posiada ponad 30-letnie doświadczenie w chirurgii gastroenterologicznej
• Jest założycielem i dyrektorem niemieckiego stowarzyszenia „Art of surgery”
• Jest uznanym w kraju specjalistą w dziedzinie chirurgii trzustki
• Stosuje sonografię śródoperacyjną oraz techniki małoinwazyjne
• Należy do prestiżowych międzynarodowych stowarzyszeń medycznych, w тому FACS

Dr Turkan Ozturk Topcu specjalizuje się w leczeniu nowotworów układu pokarmowego w Szpitalu Uniwersyteckim Biruni. Swoje doświadczenie zdobywała w MD Anderson Cancer Center oraz Sunnybrook Odette Cancer Center.

• Posiada ponad 15-letnie doświadczenie w onkologii klinicznej
• Należy do ESMO, ASCO oraz Tureckiego Towarzystwa Onkologii Klinicznej
• Szczególnie interesuje się leczeniem oraz badaniami nad rakiem żołądka

Ponad 500 pomyślnie przeprowadzonych zabiegów fundoplikacji metodą Nissena i Toupet — dr Braun specjalizuje się w małoinwazyjnych technikach laparoskopowych w chirurgii przewodu pokarmowego.

• 25 lat doświadczenia w chirurgii przewodu pokarmowego
• Ukończył szkolenie na Uniwersytecie Johnsa Hopkinsa w zakresie chirurgii wątroby, dróg żółciowych i trzustki
• Członek SICOB i ACOI — wiodących towarzystw chirurgicznych
• Koncentruje się na złożonych przypadkach GERD oraz spersonalizowanych planach leczenia